Armata Pharmaceuticals, Inc. Research And Development Expense

Quick Answer

Armata Pharmaceuticals, Inc. reported Research And Development Expense of $9.82 million for the year ending 2019.

  • Armata Pharmaceuticals, Inc. showed an increase of +17.3% in Research And Development Expense from 2018 to 2019.
  • This data is from Armata Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2020.
  • XBRL data for this metric is available from 2013 to 2019 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2013 to 2019), Armata Pharmaceuticals, Inc.'s Research And Development Expense has grown by 51.9%.
  • Historical annual values: Fiscal year 2019: $9.82 million | Fiscal year 2018: $8.37 million | Fiscal year 2017: $2.88 million | Fiscal year 2016: $5.68 million | Fiscal year 2015: $3.99 million | Fiscal year 2014: $5.81 million | Fiscal year 2013: $6.47 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: